Cyclacel Pharmaceuticals Inc. (CYCC) Gained 5.13% or 0.08 To Price $1.64 On Thursday


Cyclacel Pharmaceuticals Inc. (CYCC) gained 5.13% or 0.08 to $1.64. It is approximately 193326 shares traded, which is 461.0% compare to the average total volume 41936. The market cap of CYCC is $19.68 million. The year to date change is -6.24%. The 52 week price range is from $1.28 to $2.27. Price of CYCC have changed 4.70% during last week. It have changed 4.35% over last month, 15.59% over last 3 months, -10.40% over last 6 months and -12.36% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CYCC is 1.45. It is -11.59% below current price. The 200-day Moving Averages for CYCC is 1.61. It is -1.83% below current price. The 52-week High is 2.27. It is 38.41% from the current price. The 52-week Low is 1.28. It is -21.95% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CYCC is 8.16 on 2018-06-29. Short % to float is 3.10%. There are some statistics of CYCC. It is has market cap $19.68 million. The share outstanding is 12.00 million. The average volume is 41936. The percent of top 15 Institution holding is 25.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CYCC is -88.16%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CYCC is -69.96%.


Tags:

Share this post